New Delhi: Bharat Biotech’s Covaxin is effective against the UK variant of the virus. Taking to Twitter, Bharat Biotech said “Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape”. The tweet also enclosed a link to a report of its research findings. However, the study is yet to be peer-reviewed, ZeeNews reported.
The UK variant of the virus is considered to be 70 percent more infectious and more lethal than Wuhan one. In India, 150 cases of the UK strain have been reported.
Covaxin was approved for emergency use by the drug regulatory authority in January. The regulator, however, said the vaccine’s use will be in the clinical trial mode, which means all its recipients will be tracked and monitored, the report added.
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…